Spherix Incorporated, together with its subsidiaries, engages in the development of pharmaceutical products. It is developing D-tagatose that completed Phase 3 clinical trials for the treatment of type 2 diabetes. The company also provides technical and regulatory consulting services to biotechnology and pharmaceutical companies. Spherix Incorporated was founded in 1967 and is based in Bethesda, Maryland.